News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
German Gerresheimer Could Raise $1.5 Billion in IPO
May 25, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FRANKFURT, May 25 (Reuters) - German drug packaging maker Gerresheimer, owned by private equity group Blackstone, could raise up to 1.1 billion euros ($1.5 billion) in an initial public offering scheduled for June 11, the firm said on Friday.
Twitter
LinkedIn
Facebook
Email
Print
IPO
Europe
MORE ON THIS TOPIC
Regulatory
Tavneos no longer available for new patients in UK as Amgen awaits FDA hearing
September 2, 2026
·
2 min read
·
Tristan Manalac
Cancer
Roche finds another oncology gem in Asia with $1.5B B cell disease partnership
September 1, 2026
·
2 min read
·
Annalee Armstrong
Mergers & acquisitions
Deal-hungry Lilly strikes up to $2.9B immuno play for Merida
August 31, 2026
·
2 min read
·
Tristan Manalac
Antibody-drug conjugate (ADC)
Genentech strikes second Asia deal in a week, betting up to $1B in oncology ADC alliance with DualityBio
August 28, 2026
·
1 min read
·
Tristan Manalac
